Oakmont Partners »

Chemours shares owned by Oakmont Partners

Quarter-by-quarter ownership of Chemours (CC) shares owned by Oakmont Partners from 13F filings

Historical chart of Oakmont Partners investment in Chemours

Tip: Access up to 7 years of quarterly data

All positions including Chemours held by Oakmont Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemours by Oakmont Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $361k 14k 26.26

More positions owned by Oakmont Partners

Kla Corp Com New (KLAC)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Amazon (AMZN)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Vanguard Index Fds Value Etf (VTV)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Pfd And Incm Sec (PFF)

View all positions for Oakmont Partners

Top funds holding Chemours

Vanguard Group
Massachusetts Financial Services
Marshall Wace
Jpmorgan Chase & Co
Vaughan Nelson Investment Management
Dimensional Fund Advisors
LSV Asset Management
Bank of New York Mellon
Citadel Advisors
Norges Bank Investment Management
Charles Schwab Investment Management
Millennium Management
Legal & General Group
Squarepoint Ops
Khrom Capital Management

View all funds holding Chemours